Home
Scholarly Works
EFFICACY AND SAFETY OF FARICIMAB IN ALTIMETER: A...
Conference

EFFICACY AND SAFETY OF FARICIMAB IN ALTIMETER: A TRIAL EXPLORING BIOMARKERS OF ANG-2 INHIBITION IN PATIENTS WITH DMO

Authors

Varma D; Mar F; Amador M; Glittenberg C; Gibson K; Kotak A; Souverain A

Volume

38

Pagination

pp. 176-177

Publisher

SPRINGERNATURE

Publication Date

November 1, 2024

Conference proceedings

EYE

ISSN

0950-222X

Contact the Experts team